The complaint, originally filed under seal in January 2003, accuses Caremark of shortchanging government customers and even endangering them byselling restocked drugs that were returned through the mail but never tested for damage. Leonard claims the company continued to resell drugs for seven months without the state ever warning customers about a potential health threat. He says that Caremark changed its practices only after learning of the whistleblower complaint when it was unsealed last summer.